Multicenter Survey of the Changing In Vitro Antimicrobial Susceptibilities of Clinical Isolates of Bacteroides fragilis Group, Prevotella, Fusobacterium, Porphyromonas, and PeptostreptococcusSpecies

ABSTRACT In vitro surveys of antimicrobial resistance among clinically important anaerobes are an important source of information that can be used for clinical decisions in the choice of empiric antimicrobial therapy. This study surveyed the susceptibilities of 556 clinical anaerobic isolates from four large medical centers using a broth microdilution method. Piperacillin-tazobactam was the only antimicrobial agent to which all the isolates were susceptible. Similarly, imipenem, meropenem, and metronidazole were highly active (resistance, <0.5%), whereas the lowest susceptibility rates were noted for penicillin G, ciprofloxacin, and clindamycin. For most antibiotics, blood isolates were less susceptible than isolates from intra-abdominal, obstetric-gynecologic, and other sources. All isolates of the Bacteroides fragilis group were susceptible to piperacillin-tazobactam and metronidazole, while resistance to imipenem and meropenem was low (<2%). For these same isolates, resistance rates (intermediate and resistant MICs) to ampicillin-sulbactam, cefoxitin, trovafloxacin, and clindamycin were 11, 8, 7, and 29%, respectively. Among the individual species of the B. fragilis group, the highest resistance rates were noted among the following organism-drug combinations: for clindamycin,Bacteroides distasonis and Bacteroides ovatus; for cefoxitin, Bacteroides thetaiotaomicron, B. distasonis, and Bacteroides uniformis; for ampicillin-sulbactam,B. distasonis, B. ovatus, and B. uniformis; and for trovafloxacin, Bacteroides vulgatus. For the carbapenens, imipenem resistance was noted among B. fragilis and meropenem resistance was seen among B. fragilis, B. vulgatus, and B. uniformis. With few exceptions all antimicrobial agents were highly active against isolates of Prevotella, Fusobacterium, Porphyromonas, andPeptostreptococcus. These data further establish and confirm that clinically important anaerobes can vary widely in their antimicrobial susceptibilities. Fortunately most antimicrobial agents were active against the test isolates. However, concern is warranted for what appears to be a significant increases in resistance to ampicillin-sulbactam and clindamycin.

[1]  D. Snydman,et al.  Comparative In Vitro Activities of Clinafloxacin and Trovafloxacin against 1,000 Isolates of Bacteroides fragilisGroup: Effect of the Medium on Test Results , 2000, Antimicrobial Agents and Chemotherapy.

[2]  D. Snydman,et al.  Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  B. Aracil,et al.  High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates. , 2000, The Journal of antimicrobial chemotherapy.

[4]  E. Goldstein,et al.  Comparative Activity of Moxifloxacin in Vitro Against Obligately Anaerobic Bacteria , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[5]  D. Snydman,et al.  Multicenter Study of In Vitro Susceptibility of theBacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996 , 1999, Antimicrobial Agents and Chemotherapy.

[6]  J. Vincelette,et al.  Trends in Antimicrobial Resistance among Clinical Isolates of the Bacteroides fragilis Group from 1992 to 1997 in Montreal, Canada , 1999, Antimicrobial Agents and Chemotherapy.

[7]  J. Picazo,et al.  Activities of New Antimicrobial Agents (Trovafloxacin, Moxifloxacin, Sanfetrinem, and Quinupristin-Dalfopristin) againstBacteroides fragilis Group: Comparison with the Activities of 14 Other Agents , 1999, Antimicrobial Agents and Chemotherapy.

[8]  E. Könönen,et al.  β-Lactamase Production and Antimicrobial Susceptibility of Oral Heterogeneous Fusobacterium nucleatum Populations in Young Children , 1999, Antimicrobial Agents and Chemotherapy.

[9]  V. Rotimi,et al.  Bacteroides species highly resistant to metronidazole: an emerging clinical problem? , 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  P. Montravers,et al.  Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  D. Snydman,et al.  Attributable mortality of bacteremia associated with the Bacteroides fragilis group. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Aldridge Ke The occurrence, virulence, and antimicrobial resistance of anaerobes in polymicrobial infections , 1995 .

[13]  L. Ayers,et al.  A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States. , 1994, Diagnostic microbiology and infectious disease.

[14]  Kunitomo Watanabe,et al.  Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Kunitomo Watanabe,et al.  Conjugal transfer of imipenem resistance in Bacteroides fragilis. , 1992, The Journal of antibiotics.

[16]  M. Malamy,et al.  Transfer of beta-lactamase-associated cefoxitin resistance in Bacteroides fragilis , 1986, Antimicrobial Agents and Chemotherapy.

[17]  F. Baquero,et al.  Transferable plasmid-linked chloramphenicol acetyltransferase conferring high-level resistance in Bacteroides uniformis , 1985, Antimicrobial Agents and Chemotherapy.

[18]  J. Rosenblatt,et al.  Antimicrobial susceptibility testing of anaerobic bacteria. , 1984, Reviews of infectious diseases.

[19]  C. Smith,et al.  Transferable tetracycline resistance in Clostridium difficile , 1981, Antimicrobial Agents and Chemotherapy.

[20]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[21]  L. Chalkley,et al.  Comparative Activity of Eighteen Antimicrobial Agents against Anaerobic Bacteria Isolated in South Africa , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[22]  B. Langer "Don't look back--something might be gaining on you". , 1995, American journal of surgery.

[23]  K. Aldridge The occurrence, virulence, and antimicrobial resistance of anaerobes in polymicrobial infections. , 1995, American journal of surgery.

[24]  O. Patey,et al.  Plasmid and non-plasmid mediated reduced sensitivity to metronidazole in the Bacteroides fragilis group. , 1990, Scandinavian journal of infectious diseases.

[25]  D. Citron,et al.  Wadsworth Anaerobic Bacteriology Manual , 1980 .

[26]  M. Malamy,et al.  Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis. , 1979, The Journal of infectious diseases.

[27]  Lillian V. Holdeman,et al.  Anaerobe Laboratory manual , 1977 .